Omega Diagnostics Group PLC announced the appointment of Colin King as Chief Operating Officer from 3 August 2015.

The company announced audited final consolidated financial results for the year ended March 31, 2015. For the year, the company reported revenue from continuing operations of £12,105,319 against £11,593,870 a year ago. Operating profit was £672,970 against £527,325 a year ago. Profit before taxation was £684,258 against £543,041 a year ago. Profit for the year was £739,046 against £692,851 a year ago. Basic and diluted earnings per share on profit for the year were 0.7 pence against 0.7 pence a year ago. Adjusted profit before taxation for the year ended 31 March 2015 was £1,373,102 against £1,095,911 a year ago. Adjusted earnings per share on profit for the year were 1.3 pence against 1.2 pence a year ago. Cash flow from operating activities was £1,247,893 against £1,669,107 a year ago. Purchase of property, plant and equipment was £701,565 against £478,968 a year ago. Purchase of intangible assets was £1,394,146 against £1,880,845 a year ago.